⚡ U.S. plans to resume activities of biosites in Ukraine
💬 Chief of Nuclear, Chemical, and Biological Protection Troops of the Armed Forces of the Russian Federation Lieutenant General Igor Kirillov:
‘We have already noted that in order to reduce the political damage from Russia’s revelations, Washington was forced to limit its biological-military presence in Ukraine. Some unfinished projects were relocated to Eastern Europe, Africa, and South-East Asia.
At the same time, the United States maintains a keen interest in conducting research in Ukraine. The fact of the implementation of U.S. ‘scientific programmes’ in Ukraine was confirmed in January 2023 by John Kirby, Coordinator for Strategic Communications at the National Security Council.
Moreover, the U.S. administration retains control over some Ukrainian biosites, expecting to resume their activities once the conflict is over. In December 2022, in a letter to Ukrainian contractors, the U.S.-based CH2M Hill confirmed its intention to continue collecting dangerous pathogens in the western regions of the country while reducing the number of laboratories storing such specimens. Other tasks include control of sanitary and epidemiological situation and implementation of hardware and software complexes for biorisk management. What is more, Ukrainian organisations are required to submit reports on their work in these areas.’
WtR